Repurposing FDA-approved drugs as potential PARP inhibitors

被引：0
|
作者：
Eznarriaga, Maria [1 ]
Rahman, Taufiq [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2020年 / 177卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P070
引用
收藏
页码：2516 / 2516
页数：1
相关论文
共 50 条
  • [1] Repurposing of FDA-approved drugs as autophagy inhibitors in tumor cells
    Prerna, Kumari
    Dubey, Vikash Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (13): : 5815 - 5826
  • [2] Potential SARS-CoV-2 protease Mpro inhibitors: repurposing FDA-approved drugs
    Kouznetsova, Valentina L.
    Huang, David Z.
    Tsigelny, Igor F.
    PHYSICAL BIOLOGY, 2021, 18 (02)
  • [3] Structure-Based Repurposing of FDA-Approved Drugs as TNF-α Inhibitors
    Leung, Chung-Hang
    Chan, Daniel Shiu-Hin
    Kwan, Maria Hiu-Tung
    Cheng, Zhen
    Wong, Chun-Yuen
    Zhu, Guo-Yuan
    Fong, Wang-Fun
    Ma, Dik-Lung
    CHEMMEDCHEM, 2011, 6 (05) : 765 - 768
  • [4] Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an in silico investigation
    Ha, Christopher Heng Xuan
    Lee, Nung Kion
    Rahman, Taufiq
    Hwang, Siaw San
    Yam, Wai Keat
    Chee, Xavier Wezen
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (06): : 2146 - 2159
  • [5] Discovery of new Glyoxalase I inhibitors by repurposing of FDA-approved drugs: An in silico study
    Hoseyni, Khaled
    Sepehri, Bakhtyar
    Irani, Mehdi
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1312
  • [6] Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
    Kouznetsova, Valentina L.
    Zhang, Aidan
    Tatineni, Mahidhar
    Miller, Mark A.
    Tsigelny, Igor F.
    PEERJ, 2020, 8
  • [7] Repurposing FDA-Approved Drugs as Potential Inhibitors of SARS-CoV-2 PLpro: A Comprehensive Computational Study
    Metwaly, Ahmed M.
    Elkaeed, Eslam B.
    Alsfouk, Aisha A.
    Ibrahim, Ibrahim M.
    Soliman, Omar A.
    Elkady, Hazem
    Eissa, Ibrahim H.
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2024, 23 (09): : 1209 - 1231
  • [8] Repurposing FDA-approved drugs for anti-aging therapies
    Snell, Terry W.
    Johnston, Rachel K.
    Srinivasan, Bharath
    Zhou, Hongyi
    Gao, Mu
    Skolnick, Jeffrey
    BIOGERONTOLOGY, 2016, 17 (5-6) : 907 - 920
  • [9] Repurposing of FDA-approved drugs against cancer - focus on metastasis
    Ozsvari, Bela
    Lamb, Rebecca
    Lisanti, Michael P.
    AGING-US, 2016, 8 (04): : 567 - 568
  • [10] Scientists Repurposing FDA-Approved Drugs to Fight against Viruses
    YAN Fusheng
    Bulletin of the Chinese Academy of Sciences, 2019, 33 (03) : 187 - 188
12345